Survey reveals many women unaware of minimally invasive uterine fibroid treatments

Among women who have personally been diagnosed with uterine fibroids, more than half (53%) were presented with a hysterectomy, while fewer than 1 in 5 (20%) were presented with other less invasive options such as over-the-counter NSAIDs (19%), uterine fibroid embolization (17%), oral contraceptives (17%), and endometrial ablation (17%), according to new survey data by The Harris Poll on behalf of the Society of Interventional Radiology.

featured-image

Among women who have personally been diagnosed with uterine fibroids, more than half (53%) were presented with a hysterectomy, while fewer than 1 in 5 (20%) were presented with other less invasive options such as over-the-counter NSAIDs (19%), uterine fibroid embolization (17%), oral contraceptives (17%), and endometrial ablation (17%), according to new survey data by The Harris Poll on behalf of the Society of Interventional Radiology. Moreover, some women (17%) mistakenly think a hysterectomy, or complete removal of the uterus , is the only treatment option, including over 1 in 4 women aged 18–34 (27%). The survey also demonstrates a lack of awareness among women regarding uterine fibroids.

For instance, nearly three-fourths of women (72%) do not know they are at risk for developing uterine fibroids, yet up to 77% of adult women will develop fibroids at some point in their life. Fibroids also disproportionately affect women of color with Black women having the highest incidence. The survey findings, coupled with the low number of women who were offered a minimally invasive treatment like UFE, indicate that women are not being given all of the information they need to make their own healthcare decisions.



Not offering minimally invasive treatments like UFE in addition to the surgical treatment options is a significant oversight. Women need to be informed about the complete range of options available for treating their uterine fibroids; not just the surgical options as is mo.